about
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settingsEpidemiology and management of antiretroviral-associated cardiovascular disease.Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patientsTesamorelin: a review of its use in the management of HIV-associated lipodystrophy.Spotlight on tesamorelin in HIV-associated lipodystrophy.HIV medications: an update and review of metabolic complications.The ongoing need for good physiological investigation: obstructive sleep apnea in HIV patients as a paradigm.
P2860
Q28072729-98763FA8-89FE-47A5-9FB2-7277CB69680EQ28088839-6787D416-A5DD-4258-98D6-088A0C5051C0Q35338096-BA11F1E2-5346-45D9-81D1-8F4595C1C5C1Q36509674-0532B6CD-2335-42F9-9E1C-389ADE6CD7A9Q37888672-1B942DDD-1BAC-4C9B-9E14-FD850E55016CQ37952290-D5D656CD-5D89-4B87-A10E-3D2774026A81Q37981602-19984CAA-9B2D-4194-A179-3482A03A8247Q41970894-AC3F4EF6-9183-4B36-AEAA-169D214A3E13
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pathogenesis and treatment of HIV lipohypertrophy
@en
type
label
Pathogenesis and treatment of HIV lipohypertrophy
@en
prefLabel
Pathogenesis and treatment of HIV lipohypertrophy
@en
P2860
P1476
Pathogenesis and treatment of HIV lipohypertrophy
@en
P2093
Marshall J Glesby
Vivien L Leung
P2860
P356
10.1097/QCO.0B013E3283420EEF
P577
2011-02-01T00:00:00Z